Overview
- Description
Based in Dublin, RemedyBio is a nano scale biotechnology company pioneering ultra high throughput therapeutic and diagnostic discovery. The company’s discovery technology massively improves the speed and scale of single cell analysis, with next-generation applications in immunoncology, autoimmune disease, and infectious disease.
- Website
- Invested amount
EUR 4 000 000
- Founded
2017
- Project
- Press Release
- Country
- Ireland
- Theme
- Space
"RemedyBio continues to grow, following the business acceleration gained through EIC grant and blended finance funding. As our strategy evolves to look at further opportunities around our Nanoreactor Technology and Searchlight Discovery Platform, we will continue to identify and develop new efficacious therapies for hard-to-treat diseases."
Dan Crowley, CEO
